Retrospective, Single-Center Cohort Study of Bivalirudin Compared to Unfractionated Heparin in Patients Receiving Extracorporeal Membrane Oxygenation
When compared to heparin, bivalirudin for anticoagulation in ECMO was associated with a decreased rate of device thrombosis and greater TTR.
Authors
- Brittney Duewell (ORCID: https://orcid.org/0000-0003-4348-9830)
- Bethanne Held-Godgluck
- Joel Feih (ORCID: https://orcid.org/0000-0003-2810-5819)
- Ruta Brazauskas (ORCID: https://orcid.org/0000-0002-9239-5884)
- Stephanie Tchen (ORCID: https://orcid.org/0000-0003-4908-9280)
- Thomas Lofy
- Janelle Juul
Institutions
- Froedtert Hospital (US)
- Medical College of Wisconsin (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1177/10600280251371081
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67